跳至主要内容
临床试验/NCT04295031
NCT04295031Unknown不适用

AMEMET Study - Observational Multicentric Clinical Study: Metformin in Patients Over 65 Years With Type 2 Diabetes (DM2)

Associazione Medici Endocrinologi1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2019年10月9日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,500
试验地点
1
主要终点
metformin daily dose in diabetic outpatients type 2

研究概览

简要总结

Multicentric, observational, cross-sectional study in Italy. The aims are to evaluate the daily metformin prescribed dose and the impact of renal function and concomitant medication in diabetic patients over 65 years.

详细描述

The study was commissioned by the Italian Association of Clinical Endocrinologists (Association of Medical Endocrinologists - AME) and approved by the Ethical Committee of Cuneo Hospital. The research was open to all specialists taking care of patients with diabetes in Italy.

The primary endpoint was the evaluation of metformin dosage. Secondary endpoints were the relationship between the metformin dosage and the renal filtration rate and the relationship between the metformin dosage and the concomitant medication.

An ad hoc form was developed and used to record all medical findings. The form was emailed to all participating centers who then emailed or faxed it back to the investigator's data manager. Data were checked for accuracy.

The following data were required: age, gender, body weight and height, diabetes duration, type of metformin (classical/slow), daily dosage of metformin, reported side effects,concomitant medications.

Serum creatinine and HbA1c levels obtained within the previous two months were also required.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
65 Years 至 90 Years(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •adult outpatients (≥65 years);
  • •T2 diabetes mellitus;
  • •Taking metformin for at least six months;
  • •assuming three daily meals;
  • •capable of informed consent.

排除标准

  • •severe liver or renal failure (eGFR <30 mL/min/1.73 m2);
  • •hospitalization for any cause in the last six month;
  • •glucocorticoid treatment in the last six month;
  • •oncologic treatment in the last six month;
  • •Ramadan in the last six months.

结局指标

主要结局

metformin daily dose in diabetic outpatients type 2

时间窗: six months

relationship between metformin dose and filtration rate

次要结局

  • renal filtration rate(six months)

研究者

发起方
Associazione Medici Endocrinologi
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验